Filing Flows › Ovid Therapeutics (OVID) › How it makes money
How Ovid Therapeutics (OVID) makes money
Ovid Therapeutics (OVID) made $733K of revenue in the second quarter 2026 (Q2 2026), -88% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $733K | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $733K | -88% |
| Q4 2025 | $718K | +845% |
| Q3 2025 | $132K | -24% |
| Q2 2025 | $6.3M | 37× |
| Q1 2025 | $130K | -12% |
| Q4 2024 | $76K | -46% |
From Ovid Therapeutics' 10-Q filed Aug 13, 2026 (on EDGAR).
Questions
How does Ovid Therapeutics make money?
Ovid Therapeutics (OVID) made $733K of revenue in the second quarter 2026 (Q2 2026), -88% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.